5/27/2025CTTQ's Anlotinib Combination Shows Promise

5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ

5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...

5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...

5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...

5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD

5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment

5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...

5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...

5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL

5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/20253SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC

5/20/2025ArkBio Announces Positive Phase II Results of AK3280

5/20/2025BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial

5/20/2025Nuance Reports Positive Top-Line Results from Phase 3 Trial of Ensifen...

5/16/2025Nuance Pharma Reports Positive Phase 3 Results for Ensifentrine in Chi...

5/16/2025NMPA Approves CANbridge's Velaglucerase Beta for Gaucher Disease

5/16/2025China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...

5/16/2025China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...

5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...

5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...

5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...

5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...

5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...

5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...

5/14/2025BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...

5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M

5/12/2025CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...

Page:11/20 Total number of articles:592: [First][<<] [9] [10] [11] [12] [13] [>>] [End]